Current Oncology Reports

Papers
(The TQCC of Current Oncology Reports is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer181
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas119
New Developments in VHL-Associated Neuroendocrine Neoplasms118
NRG1 Fusions: The New Kid on the Block90
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review62
Immunotherapy in Biliary Tract Cancers: Where Are We?60
Cardiotoxic Effects Following CAR-T Cell Therapy: A Literature Review56
Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan55
The Difficult Airway in Patients with Cancer54
The Microbiome in Advanced Melanoma: Where Are We Now?52
Head and Neck Mucosal Melanoma: Where Are We Now?48
Current Trends and Challenges of Microbiome Research in Prostate Cancer44
AXL Inhibitors: Status of Clinical Development42
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients41
An Overview of Angiogenesis in Bladder Cancer40
Cellular Therapy in NSCLC: Between Myth and Reality40
Novel Surgical Initiatives in Gastroenteropancreatic Neuroendocrine Tumours39
Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision—a Literature Review39
Appendiceal Neuroendocrine Neoplasms: an Update for 202339
How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?35
Targeting the PI3K Pathway in Gynecologic Malignancies33
Proton Therapy in The Treatment of Head And Neck Cancers- Review31
Breast cancer Treatment and Fertility Preservation: A Narrative Review of Impacts, Strategies and Ethical Considerations30
A Systematic Review and a Meta-analysis of Randomized Controlled Trials’ Control Groups in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)30
CAR-T Therapies in Solid Tumors: Opportunities and Challenges30
Development of Effective Siglec-9 Antibodies Against Cancer28
Geographical Disparities in Colorectal Cancer in Canada: A Review28
Evolving Role of CAR T Cell Therapy in First- and Second-Line Treatment of Large B Cell Lymphoma27
Surgical Management of the Primary Tumor in Stage IV Small Intestinal Neuroendocrine Tumors: To Operate or Not to Operate, That Is the Question27
Current Management of Neuroendocrine Tumour Liver Metastases27
Use of Circulating Tumor DNA to Guide Decision-making in Adjuvant Colon Cancer26
Antibody-Drug Conjugates in Breast Cancer: The Road Towards Biologically-Informed Selection and Sequencing26
Vascular Inflammation, Cancer, and Cardiovascular Diseases25
Biomarkers in the Immuno-oncology Interface of Triple Negative Breast Cancer: A Scoping Review with Perioperative Considerations25
Pre- and Post-Microsurgical Rehabilitation Interventions and Outcomes on Breast Cancer–Related Lymphedema: a Systematic Review25
Diagnostic Accuracy of Liquid Biopsy for Oral Potentially Malignant Disorders and Head and Neck Cancer: an Overview of Systematic Reviews25
Role of the Microbiome and Diet for Response to Cancer Checkpoint Immunotherapy: A Narrative Review of Clinical Trials24
Elderly Rectal Cancer: An Updated Review23
Inequities Among Cancer Caregivers with Diverse Identities: A Review of the Literature and Future Directions23
Dedifferentiated Chondrosarcoma: Diagnostic Controversies and Emerging Therapeutic Targets23
Surgery for Recurrent Epithelial Ovarian Cancer23
The Evidence for Using Artificial Intelligence to Enhance Prostate Cancer MR Imaging22
Small Cell and Other Rare Histologic Types of Cervical Cancer22
Current Diagnostic Tools for Breast Cancer-Related Lymphedema22
Management of Peripheral T-cell Lymphomas and the Role of Transplant21
Current Status on Management of Primary Plasma Cell Leukemia21
Advancements in the Diagnosis, Treatment, and Risk Stratification of Non-Muscle Invasive Bladder Cancer21
Therapeutic Management in Elderly Male Breast Cancer Patients: A Scoping Review21
Unveiling the Hidden Links: Periodontal Disease, Fusobacterium Nucleatum, and Cancers20
Epidemiology of Cancer in Older Adults: A Systematic Review20
Human Epidermal Growth Factor Receptor 2 Positive Advanced Gastric or Esophagogastric Adenocarcinoma: Reflecting on the Past to Gain a New Insights20
Integrative Medicine Across the Pediatric Cancer Care Trajectory: A Narrative Review20
History of Leukemia, Revisited20
Intratumoral Immunotherapy: Is It Ready for Prime Time?20
Nasal Cavity and Paranasal Sinus Cancer: Diagnosis and Treatment19
Multimodality Therapies for Localized Prostate Cancer19
Management of Pathologic Node-Positive Prostate Cancer following Radical Prostatectomy19
Return to Intended Oncological Therapy: State of the Art and Perspectives19
Limb Amputations in Cancer: Modern Perspectives, Outcomes, and Alternatives18
Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions18
15 Years Old ALK Gene from Birth to Adolescence; Where to in NBL18
Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis18
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development18
Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours18
Racial Disparities in Breast Cancer: from Detection to Treatment18
Cured or Not? Long-term Outcomes of Immunotherapy Responders. Focus on Melanoma18
Blood–Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade18
Prevention of Ovarian Cancer: Where are We Now and Where are We Going?18
Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer18
Oral Health in Patients with History of Head and Neck Cancer: Complexity and Benefits of a Targeted Oral Healthcare Pathway17
CAR T-cell Therapy for Central Nervous System Lymphoma17
CDK4/6 inhibitors: The Devil is in the Detail17
Cardio-Oncology in Childhood: State of the Art17
Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas17
Resectability versus Operability in Early-Stage Non-Small Cell Lung Cancer17
Options for Rescue Treatment of Patients with AL Amyloidosis Exposed to Upfront Daratumumab16
Advances in Treatment of Waldenström Macroglobulinemia16
Correction: Enhanced Recovery in Gynecologic Oncology Surgery—State of the Science16
Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer16
Surviving Burnout as an Oncologist16
Integrative Geriatric Oncology: A Review of Current Practices16
Radiogenomics as an Integrated Approach to Glioblastoma Precision Medicine16
Fertility-Sparing and Less Radical Surgery for Cervical Cancer15
Intracranial Germinomas: Diagnosis, Pathogenesis, Clinical Presentation, and Management15
Defining The Role for Hormone Therapy in Biochemically Recurrent Prostate Cancer: What Counts as a Win for Patients?15
Epidemiology of cancer in older adults: a systematic review of age-related differences in solid malignancies treatment15
Pelvic Floor Therapy and Initial Interventions for Pelvic Floor Dysfunction in Gynecologic Malignancies15
New Developments in Image-Guided Percutaneous Irreversible Electroporation of Solid Tumors15
Traditional Chinese Medicine Herbs for Breast Cancer Prevention and Survival: A Narrative Review of Epidemiological Studies from Taiwan15
Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis15
Use of Antihyperglycemic Drugs and Risk of Cancer in Patients with Diabetes15
Perioperative Blood Transfusions and Cancer Progression: A Narrative Review15
Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism15
1.6416800022125